chr1-46683384-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014774.3(EFCAB14):āc.1228A>Gā(p.Lys410Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000805 in 1,613,954 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014774.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EFCAB14 | NM_014774.3 | c.1228A>G | p.Lys410Glu | missense_variant | 10/11 | ENST00000371933.8 | NP_055589.1 | |
EFCAB14-AS1 | NR_038827.1 | n.268+1120T>C | intron_variant, non_coding_transcript_variant | |||||
EFCAB14-AS1 | NR_038828.1 | n.185-3289T>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EFCAB14 | ENST00000371933.8 | c.1228A>G | p.Lys410Glu | missense_variant | 10/11 | 1 | NM_014774.3 | ENSP00000361001 | P2 | |
EFCAB14-AS1 | ENST00000442839.5 | n.185-3289T>C | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.000453 AC: 69AN: 152210Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000835 AC: 21AN: 251394Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135874
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461744Hom.: 0 Cov.: 30 AF XY: 0.0000358 AC XY: 26AN XY: 727168
GnomAD4 genome AF: 0.000453 AC: 69AN: 152210Hom.: 0 Cov.: 33 AF XY: 0.000511 AC XY: 38AN XY: 74374
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2024 | The c.1228A>G (p.K410E) alteration is located in exon 10 (coding exon 10) of the EFCAB14 gene. This alteration results from a A to G substitution at nucleotide position 1228, causing the lysine (K) at amino acid position 410 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at